World Orphan Drug Alliance (WODA)

European Market-Entry Strategy for Biopharma Companies

World Orphan Drug Alliance (WODA) is a global alliance of regional full-service distributors for orphan drugs. EffRx has combined forces together with twelve other orphan drugs experts – Medis, Vector Pharma, Orpharm, Veld Pharma, Arrotex Pharmaceuticals, Celystra Pharma, Healthmount, Path Pharma, CTS and Nxera Pharma – to reach rare disease patients in complex and often overlooked countries.

WODA covers 158 countries in the following regions:
  • Central and Eastern Europe (Medis)
  • Latin America (Innovative Medicines Group)
  • Middle East, North Africa & Turkey (Vector Pharma)
  • Russia & the CIS region (Orpharm)
  • Switzerland (EffRx Pharmaceuticals SA)
  • Sub‑Saharan Africa (Veld Pharma)
  • Australia & New Zealand (Arrotex Pharmaceuticals)
  • Canada (Celystra Pharma)
  • Greater China (Healthmount)
  • Greece, Cyprus & Malta (Path Pharma)
  • Israel (CTS)
  • Japan & South Korea (Nxera Pharma)
WODA provides pharmaceutical & biotech companies with a rare disease portfolio:
  • Access to 210 million potential rare disease patients
  • Full-service solutions
  • Deep understanding of local healthcare systems
  • Single point of contact
  • Flexible approach
MEDIS-LOGO_color-300x80
orpharm-300x67